Frequent CEA measurements in follow-up of colorectal carcinoma.
- Conditions
- follow-upcolorectal cancerCarcinoembryonic Antigen
- Registration Number
- NL-OMON19879
- Lead Sponsor
- niveristy Medical Center Groningen
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 1800
Inclusion Criteria
1. Patients with stage II- III –IV colorectal carcinoma after curative resection (R0 resection) from 1-1-2007;
2. All new patients with II-III-IV colorectal carcinoma eligible for curative resection;
Exclusion Criteria
1. Patients with other malignancies except basocellular carcinoma of the skin;
2. Patients not medically fit for metastasectomy;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of curatively treatable recurrent or metachronous metastatic disease in the intervention group in comparison with the control group.
- Secondary Outcome Measures
Name Time Method 1. Disease free survival, recurrent-free survival, overall survival;<br /><br>2. Quality of Life in patients undergoing more intensified follow-up schemes;<br /><br>3. Costs and effectiveness of introducing a software tool to support the frequent CEA measrurements.